UniProt ID | SHRPN_HUMAN | |
---|---|---|
UniProt AC | Q9H0F6 | |
Protein Name | Sharpin | |
Gene Name | SHARPIN | |
Organism | Homo sapiens (Human). | |
Sequence Length | 387 | |
Subcellular Localization | Cytoplasm, cytosol . Cell junction, synapse. Enriched at synaptic sites in mature neurons where it colocalizes with SHANK1.. | |
Protein Description | Component of the LUBAC complex which conjugates linear polyubiquitin chains in a head-to-tail manner to substrates and plays a key role in NF-kappa-B activation and regulation of inflammation. LUBAC conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in activation of the canonical NF-kappa-B and the JNK signaling pathways. Linear ubiquitination mediated by the LUBAC complex interferes with TNF-induced cell death and thereby prevents inflammation. LUBAC is proposed to be recruited to the TNF-R1 signaling complex (TNF-RSC) following polyubiquitination of TNF-RSC components by BIRC2 and/or BIRC3 and to conjugate linear polyubiquitin to IKBKG and possibly other components contributing to the stability of the complex. Together with FAM105B/otulin, the LUBAC complex regulates the canonical Wnt signaling during angiogenesis.. | |
Protein Sequence | MAPPAGGAAAAASDLGSAAVLLAVHAAVRPLGAGPDAEAQLRRLQLSADPERPGRFRLELLGAGPGAVNLEWPLESVSYTIRGPTQHELQPPPGGPGTLSLHFLNPQEAQRWAVLVRGATVEGQNGSKSNSPPALGPEACPVSLPSPPEASTLKGPPPEADLPRSPGNLTEREELAGSLARAIAGGDEKGAAQVAAVLAQHRVALSVQLQEACFPPGPIRLQVTLEDAASAASAASSAHVALQVHPHCTVAALQEQVFSELGFPPAVQRWVIGRCLCVPERSLASYGVRQDGDPAFLYLLSAPREAPATGPSPQHPQKMDGELGRLFPPSLGLPPGPQPAASSLPSPLQPSWSCPSCTFINAPDRPGCEMCSTQRPCTWDPLAAAST | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
29 | Methylation | LAVHAAVRPLGAGPD HHHHHHHCCCCCCCC | 18.92 | 24384663 | |
80 | Phosphorylation | PLESVSYTIRGPTQH CHHHCEEEEECCCCC | 9.19 | 24719451 | |
127 | Phosphorylation | TVEGQNGSKSNSPPA EEECCCCCCCCCCCC | 40.22 | 28348404 | |
129 | Phosphorylation | EGQNGSKSNSPPALG ECCCCCCCCCCCCCC | 44.21 | 30278072 | |
131 | Phosphorylation | QNGSKSNSPPALGPE CCCCCCCCCCCCCCC | 39.07 | 30278072 | |
143 | Phosphorylation | GPEACPVSLPSPPEA CCCCCCCCCCCCCCC | 21.50 | 30206219 | |
146 | Phosphorylation | ACPVSLPSPPEASTL CCCCCCCCCCCCCCC | 59.38 | 25159151 | |
151 | Phosphorylation | LPSPPEASTLKGPPP CCCCCCCCCCCCCCC | 32.39 | 22199227 | |
152 | Phosphorylation | PSPPEASTLKGPPPE CCCCCCCCCCCCCCC | 39.27 | 30576142 | |
154 | Ubiquitination | PPEASTLKGPPPEAD CCCCCCCCCCCCCCC | 70.25 | - | |
165 | Phosphorylation | PEADLPRSPGNLTER CCCCCCCCCCCCCHH | 34.91 | 29255136 | |
170 | Phosphorylation | PRSPGNLTEREELAG CCCCCCCCHHHHHHH | 36.68 | 23927012 | |
178 | Phosphorylation | EREELAGSLARAIAG HHHHHHHHHHHHHHC | 17.16 | 23927012 | |
189 | Ubiquitination | AIAGGDEKGAAQVAA HHHCCCHHHHHHHHH | 59.60 | 21890473 | |
189 (in isoform 1) | Ubiquitination | - | 59.60 | 21890473 | |
189 | Ubiquitination | AIAGGDEKGAAQVAA HHHCCCHHHHHHHHH | 59.60 | 21890473 | |
189 (in isoform 2) | Ubiquitination | - | 59.60 | 21890473 | |
189 | Ubiquitination | AIAGGDEKGAAQVAA HHHCCCHHHHHHHHH | 59.60 | 22053931 | |
224 | Phosphorylation | GPIRLQVTLEDAASA CCEEEEEEHHHHHHH | 16.09 | - | |
282 | Phosphorylation | CLCVPERSLASYGVR CEEECHHHHHHCCCC | 26.99 | 27251275 | |
301 | Phosphorylation | PAFLYLLSAPREAPA CEEEEEEECCCCCCC | 33.36 | 24719451 | |
309 | Phosphorylation | APREAPATGPSPQHP CCCCCCCCCCCCCCC | 48.87 | 28450419 | |
312 | Phosphorylation | EAPATGPSPQHPQKM CCCCCCCCCCCCCCC | 38.24 | 25159151 | |
318 | Ubiquitination | PSPQHPQKMDGELGR CCCCCCCCCCCCHHH | 43.33 | 21890473 | |
318 (in isoform 1) | Ubiquitination | - | 43.33 | 21890473 | |
318 | Ubiquitination | PSPQHPQKMDGELGR CCCCCCCCCCCCHHH | 43.33 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SHRPN_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SHRPN_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SHRPN_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. |